Sustained-Release Niacin for Prevention of Migraine Headache David A. Velling, MD, David W. Dodick, MD, Jesse J. Muir, MD Mayo Clinic Proceedings Volume 78, Issue 6, Pages 770-771 (June 2003) DOI: 10.4065/78.6.770 Copyright © 2003 Mayo Foundation for Medical Education and Research Terms and Conditions
Figure 1 Kynurenine pathway. Niacin and its derivatives act as negative feedback regulators, possibly increasing the conversion of dietary L-tryptophan to serotonin. Mayo Clinic Proceedings 2003 78, 770-771DOI: (10.4065/78.6.770) Copyright © 2003 Mayo Foundation for Medical Education and Research Terms and Conditions